SlideShare a Scribd company logo
Letter of Intent Town Hall for
Applicants
August 2013 Cycle
1
Agenda
Introductions
About PCORI
PCORI Funding Announcements (PFA)
Overview of PFA
Merit Review Criteria
Letter of Intent Overview
Resources
Live Q&A
Submitting Questions:
Submit questions via
the chat function in
Meeting Bridge
Ask a question via phone
(an operator will standby
to take your questions)
2
Introductions
Martin Duenas, MPA
Contracts Director
James Hulbert
Contracts Administrator
Kirstin Margosian, MA
Contracts Coordinator
3
Rachael Fleurence, PhD
Program Director
About PCORI
4
PCORI’s Mission and Vision
 The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health
research organization authorized by the Patient Protection and Affordable Care Act of 2010.
 PCORI funds patient-centered research to assist patients, caregivers, and other stakeholders in
making informed health decisions.
Mission
PCORI helps people make
informed healthcare
decisions and improves
healthcare delivery and
outcomes by producing and
promoting high integrity,
evidence-based information
that comes from research
guided by patients,
caregivers, and the broader
healthcare community.
Vision
Patients and the public have
the information they need to
make decisions that reflect
their desired health
outcomes.
5
Research Done Differently
PCORI’s unique contribution to this field of research is its dedicated focus on outcomes that matter
most to patients.
Inclusion of patient-centered outcomes is therefore a
necessary component of PCORI-funded research.
PCORI involves patients and the entire healthcare
community in every step of the research
process — from selecting research questions to study,
to the actual conduct of research, to sharing the
research findings through platforms and channels that
are accessible to everyone.
6
PCORI Funding Announcements
7
Overview of PFAs
To solicit research proposals, PCORI regularly releases funding announcements that invite researchers
to submit applications to receive funding to conduct research projects:
Addressing Disparities
Assessment of Prevention, Diagnosis, and Treatment Options
Communication and Dissemination Research
Improving Healthcare Systems
Improving Methods for Conducting Patient-Centered Outcomes Research
8
Improving Methods for Conducting Patient-Centered
Outcomes Research
9
Improving Methods for Conducting
Patient-Centered Outcomes Research
10
In this PFA, we seek to fund projects that:
 Improve methods for engaging patients/stakeholders in
PCOR and for evaluating the impact of this patient/
stakeholder engagement.
 Improve methods for systematic review of PCOR topics,
including selection and prioritization of topics.
 Improve the validity and/or efficiency of analytic methods
and data sources utilized in PCOR research.
 Improve methods to support the collection of Patient-
Reported Outcomes and Patient-Centered Outcomes.
 Improve methods to enhance the reproducibility,
transparency, and replication of PCOR research.
 Improve approaches for training researchers, patients, and
other stakeholders in PCOR methods.
Available funds: Up to $8 Million
Studies PCORI Is Not Soliciting Under This
PFA
Studies whose primary focus is not on improving methods
for PCOR: Studies should address gaps identified under the
research areas of interest in the PFA and the Methodology
Committee report.
Studies whose primary focus is on developing or studying
a disease-specific intervention, model, test, instrument,
tool or other items without the primary objective being
to address a methodological gap in PCOR as identified in
the Methodology Committee report or in other recognized
sources.
Examples of non-responsive studies:
1. Study whose main focus is to
evaluate the response to an
intervention in patients with
a specific disease.
2. Development of a tool to improve
patient-physician communication
around a difficult diagnosis.
11
Broad Research Topics of Interest
The following topics areas are areas of research that PCORI might be interested in:
 Development of methods for patient-centeredness.
 Research in methods to conduct systematic reviews of patient-centered CER.
 Development of methods for generating, selecting, and prioritizing topics for research and for
including patients and stakeholders in the peer-review process.
 Development and refinement of general analytic methods.
 Development and refinement of design-specific analytic methods.
 Research that determines the validity and efficiency of data sources commonly used in PCOR.
 Research related to Patient-Centered Outcomes (PCOs) and Patient-Reported Outcomes (PROs).
 Research in methods to enhance the reproducibility, transparency, and replication of PCOR.
12
Merit Review Criteria
13
Merit Review Criteria
Applicants must respond to the five PCORI Merit Review Criteria.
1. Impact on the field of PCOR
methods
2. Potential for study to
improve PCOR methods
3. Technical merit 4. Patient-centeredness
5. Patient and stakeholder
engagement
14
Criterion 1: Impact on the field of
PCOR Methods
Refers to the extent that the proposed methods are needed in the field of PCOR.
 How often would these methods be used, and how many PCOR studies would
benefit from these improved methods?
 Do existing methods weaken the validity of PCOR studies, and would improved
methods therefore increase the validity of PCOR findings?
15
Criterion 2: Potential for study to
improve PCOR Methods
Refers to the potential of the proposed methodological investigation and its results to
change methodological practices in ways that improve PCOR and the decisions made
by patients.
 Does the research question address a critical gap in current methodological
understanding as noted in the Methodology Committee Report or in
other sources?
 Is the proposed approach feasible and likely to result in new standards or in the
improvement of existing standards?
16
Criterion 3: Technical merit
Refers to the technical merit of the proposal.
 Is there a clear research plan with rigorous methods and key milestones clearly
articulated? Do the study methods reflect state-of the-art thinking and practice in
the methodological area, so that results are likely to be accepted and heeded?
 Is the research team appropriately trained and experienced to carry out the
planned studies?
 Is the research environment sufficient to support the conduct of the work, and are
appropriate resources available?
 Will the proposed methods help support the inclusion and study of diverse
populations with respect to age, gender, race, ethnicity, geography, or clinical
status, or, alternatively, do the methods support the inclusion of previously
understudied populations in PCOR?
17
Criterion 4: Patient-centeredness
Refers to the level of patient-centeredness of the proposal.
 Is the proposed methodological investigation specifically linked to improving PCOR
methods, and specifically to the improved study of comparisons and patient-
centered outcomes that are relevant and valued by patients, caregivers, and
clinicians?
 For relevant studies, how credible are the application’s claims that engaged
patients and stakeholders will exert meaningful influence on the design and
conduct of the research, to ensure patient-centeredness of the questions and
outcomes addressed?
18
Criterion 5: Patient and
stakeholder engagement
Refers to the level of engagement of patients and stakeholders in the proposed
project.
 Where applicable, applications need to demonstrate patient and stakeholder
engagement through the integration of patients and stakeholders in the
development of the research plan and in key elements of the proposed project
including:
• Participation in formulation of research questions
• Defining essential characteristics of the study, participants,
comparators, and outcomes
• Monitoring study conduct and progress
• Dissemination of research results
 If the project has not included patient and stakeholder engagement (for example,
in the area of analytic methods), has the application justified their non-inclusion?
19
Letter of Intent (LOI) Submission: Deep Dive
20
Understanding the Letter of Intent (LOI)
A LOI is required in order to submit an
application.
LOI’s are NOT scored.
Applicants will NOT receive an invitation to
submit an application after submitting a LOI.
An Investigator can only be listed as a PI on
one.
Of note: PCORI encourages applicants to submit their LOI and application before
the stated due date. LOIs and applications are due 5:00 pm ET.
21
Eligibility Requirements
Applications may be submitted by:
 Any private sector research organization, including any:
• non-profit organization
• for-profit organization
 Any public sector research organization, including any:
• university or college
• hospital or healthcare system
• Laboratory or manufacture
• unit of state or local government
 Foreign Organizations
 Nondomestic Components of Organizations based in the United States
Please Note: Individuals are not eligible to submit applications to PCORI.
22
Budget and Period Limitations
Budget
• Maximum $250,000 direct costs per year
• Indirect costs are capped at 40%
• *Request for exception can be made during the
LOI submission
Period of Performance
• Maximum of three years
• PCORI encourages projects of shorter duration
• *Request for exception can be made during the
LOI submission
*Of note: Approval or denial decisions may take up to four months. Please
plan accordingly, and factor this into your decision to submit a request.
23
Letter of Intent
24
The Letter of Intent includes:
 Organizational information
 Information about Key Personnel
 Technical abstract (3,000 character limit)
• Background: State the problem or methodological gap your research
intends to address, including the rationale for tackling this problem.
• Objectives: Briefly describe the specific aims of the study, including the
methods gaps addressed.
• Methods: Give a concise description of the steps involved in the
development of the new methodology.
• Anticipated impact: Describe the anticipated impact the study results will
have on the field of PCOR methods.
Of note: This abstract may be used to determine programmatic fit.
Key Dates: August 15 2013
Key Dates: PCORI Funding Announcements
Action August 2013 Cycle
System Opening Date May 15
Letter of Intent (LOI) Due
Date
June 15
Informational Training
Programs
July – August
Application Deadline August 15
Merit Review Dates September - November
Awards Announced December / January
Earliest Start Date January
25
Frequently Asked Questions
(Programmatic)
 How do I know if my research is of interest to PCORI?
• We encourage you to read the PCORI Funding Announcements (PFAs) carefully
and other background material on our website to understand our goals and the
PFA you are considering.
 Can I speak with someone at PCORI about the suitability of my research
question?
• Currently, PCORI does not have dedicated individuals to speak with applicants
regarding submission questions. Applicants and potential applicants with
questions should submit those inquiries via pfa@pcori.org.
 Is there a specific disease or condition that is a priority for PCORI?
• No. PCORI is concerned with patient outcomes, across a range of conditions
and treatments. PCORI will periodically issue PFAs that focus on specific
diseases or conditions within or across funding areas.
26
Frequently Asked Questions
(Administrative)
 Can I switch PFAs after a LOI has been submitted?
• No. It is not possible to submit an LOI to one funding announcement and the
full application to another.
 How much can the research proposed in my application differ from that initially
described in my Letter of Intent (LOI)?
• The information provided in the LOI, including the study title, may be changed
in the final application. Only two things may not differ:
• The PFA may not change.
• The budget may not exceed direct cost and/or project period, as listed
within the PFA, if permission was not requested at LOI submission.
 Can I list a different PI in the final application than was listed in the Letter of Intent
(LOI)?
• Yes. The PI listed on your final application may differ from the PI listed in the
LOI.
27
Resources
28
Resources
View training materials through
the Quick Links for Applicants
bar. Access:
• Application training
• Opportunities for webinars
• Reviewer training
Visit the Funding Center for:
• PFAs
• Templates
• Instructions
• Key dates
• FAQ’s
29
Questions
Submitting Questions:
Submit questions via
the chat function in
Meeting Bridge
Ask a question via phone
(press #7 on your phone)
Please use this time to ask any
question you may have about the PFA
or the LOI submission process.
If we are unable to address your
question during this time, e-mail the
help desk at pfa@pcori.org.
30

More Related Content

PDF
Special Board of Governors Teleconference/Webinar
PDF
PCORI Methodology Committee Report
PPTX
Patient Recruitment Insights
PDF
CROs Driving Changes in Patient Recruitment
PDF
Clinical Trial Recruitment & Retention
PDF
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
PPTX
Newhouse arkansas 4-7-14(v2)
PPT
Clinical Trial Recruitment
Special Board of Governors Teleconference/Webinar
PCORI Methodology Committee Report
Patient Recruitment Insights
CROs Driving Changes in Patient Recruitment
Clinical Trial Recruitment & Retention
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Newhouse arkansas 4-7-14(v2)
Clinical Trial Recruitment

What's hot (20)

PPT
Patient recruitment
PDF
Recruitment Metrics from a Direct-to-Patient Approach to Enroll Patients in a...
PPTX
Impacting Recruitment from a Sponsor / CRO Perspective
PDF
Patient recruitment into clinical trials presentation
PDF
Clinical trial recruitment overview
PDF
Basic Study Recruitment and Regulatory Issues: Which Methods are Appropriate?
PPTX
Methods of patient recruitment
PDF
National Priorities and Research Agenda
PDF
BIOMEDICAL STRATEGY - Patient Recruitment Presentation
PPTX
Health research priorities 2015
PDF
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
PPTX
Best Practices in Clinical Study Recruitment
PDF
PDF
OTC Electronic Clinical Trial Recruitment
PDF
Patient Perspectives on Lay Trial Results Summaries
PDF
Best strategies for successful recruitment and retention
PDF
HEOR Fellowship Practices Reviewed
PPTX
Research for Patient Benefit Programme: Lecture, Tuesday 27 June 2017
PDF
Novartis-HEOR-Fellowship-Brochure-2016-2018
PPT
Implementing Patient & Public Involvement in Research: 27.06.2017
Patient recruitment
Recruitment Metrics from a Direct-to-Patient Approach to Enroll Patients in a...
Impacting Recruitment from a Sponsor / CRO Perspective
Patient recruitment into clinical trials presentation
Clinical trial recruitment overview
Basic Study Recruitment and Regulatory Issues: Which Methods are Appropriate?
Methods of patient recruitment
National Priorities and Research Agenda
BIOMEDICAL STRATEGY - Patient Recruitment Presentation
Health research priorities 2015
Mosio's Clinical Trial Patient Recruitment and Retention Ebook (First Edition)
Best Practices in Clinical Study Recruitment
OTC Electronic Clinical Trial Recruitment
Patient Perspectives on Lay Trial Results Summaries
Best strategies for successful recruitment and retention
HEOR Fellowship Practices Reviewed
Research for Patient Benefit Programme: Lecture, Tuesday 27 June 2017
Novartis-HEOR-Fellowship-Brochure-2016-2018
Implementing Patient & Public Involvement in Research: 27.06.2017
Ad

Similar to PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Outcomes Research (20)

PDF
PFA Applicant Town Hall Improving Healthcare Systems
PDF
Improving the Impact of Patient-Engaged Research
PDF
The Power of Partnership in Research: Improving Healthcare Outcomes in Unders...
PPT
Pcori hickam ucsf 1 16 2014 ver 2
PDF
Launching the Eugene Washington PCORI Engagement Awards Program
PPTX
UCSF CER - What PCORI Wants (Symposium 2013)
PDF
PCORnet: Building Evidence through Innovation and Collaboration
PPTX
Luke Gelinas, "Recommendations for PCOR Oversight: Seeking Consensus"
PDF
Latino Roundtable Discussion
PDF
Board of Governors Meeting Denver, CO
PDF
The National Patient-Centered Clinical Research Network: Patient-Powered Rese...
PDF
Improving Healthcare Systems Program
PPT
How Prescription Drugs are Approved in Canada
PDF
PCORI Methodology Committee Report
PPTX
Levels of Engagement and Appropriate Methods
PDF
Pcori webinar slides
PDF
Patient Engagement Lunchtime Learning: PREPPP info session
PDF
PIHCI programmatic grants webinar (en) for circulation
PPT
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
PDF
Involving patients in research what have we done and how did we do it jean ...
PFA Applicant Town Hall Improving Healthcare Systems
Improving the Impact of Patient-Engaged Research
The Power of Partnership in Research: Improving Healthcare Outcomes in Unders...
Pcori hickam ucsf 1 16 2014 ver 2
Launching the Eugene Washington PCORI Engagement Awards Program
UCSF CER - What PCORI Wants (Symposium 2013)
PCORnet: Building Evidence through Innovation and Collaboration
Luke Gelinas, "Recommendations for PCOR Oversight: Seeking Consensus"
Latino Roundtable Discussion
Board of Governors Meeting Denver, CO
The National Patient-Centered Clinical Research Network: Patient-Powered Rese...
Improving Healthcare Systems Program
How Prescription Drugs are Approved in Canada
PCORI Methodology Committee Report
Levels of Engagement and Appropriate Methods
Pcori webinar slides
Patient Engagement Lunchtime Learning: PREPPP info session
PIHCI programmatic grants webinar (en) for circulation
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
Involving patients in research what have we done and how did we do it jean ...
Ad

More from Patient-Centered Outcomes Research Institute (20)

PDF
New Patient-Centered Study on Preventing Fall-Related Injuries in Older Adults
PDF
From Research to Practice: New Models for Data-sharing and Collaboration to I...
PDF
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
PDF
Advisory Panel on Clinical Trials Spring 2014 Meeting
PDF
Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...
PDF
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1
PDF
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2
PDF
Advisory Panel on Addressing Disparities Spring 2014 Meeting
PDF
Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...
PDF
Advisory Panel on Rare Disease Spring 2014 Meeting
PDF
PCORnet: Building Evidence through Innovation and Collaboration
PDF
Patient-Powered Research Network Workshop
PDF
Patient-Powered Research Network Workshop
PDF
Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...
PDF
Promising Practices of Meaningful Engagement in the Conduct of Research
PDF
PCORI Merit Review: Learning from Patients, Scientists and other Stakeholders
PDF
Opening a Pipeline to Patient-Centered Research Proposals
PDF
Special Board of Governors Teleconference/Webinar
PDF
PCORI Mission and Mandate to Fund CER
PDF
What Are We Looking For? Building a National Infrastructure for Conducting PCOR
New Patient-Centered Study on Preventing Fall-Related Injuries in Older Adults
From Research to Practice: New Models for Data-sharing and Collaboration to I...
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
Advisory Panel on Clinical Trials Spring 2014 Meeting
Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2
Advisory Panel on Addressing Disparities Spring 2014 Meeting
Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...
Advisory Panel on Rare Disease Spring 2014 Meeting
PCORnet: Building Evidence through Innovation and Collaboration
Patient-Powered Research Network Workshop
Patient-Powered Research Network Workshop
Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...
Promising Practices of Meaningful Engagement in the Conduct of Research
PCORI Merit Review: Learning from Patients, Scientists and other Stakeholders
Opening a Pipeline to Patient-Centered Research Proposals
Special Board of Governors Teleconference/Webinar
PCORI Mission and Mandate to Fund CER
What Are We Looking For? Building a National Infrastructure for Conducting PCOR

Recently uploaded (20)

DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
Respiratory drugs, drugs acting on the respi system
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPT
Obstructive sleep apnea in orthodontics treatment
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Human Health And Disease hggyutgghg .pdf
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
Breast Cancer management for medicsl student.ppt
PPTX
CME 2 Acute Chest Pain preentation for education
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
History and examination of abdomen, & pelvis .pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
Respiratory drugs, drugs acting on the respi system
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
OPIOID ANALGESICS AND THEIR IMPLICATIONS
Obstructive sleep apnea in orthodontics treatment
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
ASRH Presentation for students and teachers 2770633.ppt
Human Health And Disease hggyutgghg .pdf
MENTAL HEALTH - NOTES.ppt for nursing students
Breast Cancer management for medicsl student.ppt
CME 2 Acute Chest Pain preentation for education
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
History and examination of abdomen, & pelvis .pptx

PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Outcomes Research

  • 1. Letter of Intent Town Hall for Applicants August 2013 Cycle 1
  • 2. Agenda Introductions About PCORI PCORI Funding Announcements (PFA) Overview of PFA Merit Review Criteria Letter of Intent Overview Resources Live Q&A Submitting Questions: Submit questions via the chat function in Meeting Bridge Ask a question via phone (an operator will standby to take your questions) 2
  • 3. Introductions Martin Duenas, MPA Contracts Director James Hulbert Contracts Administrator Kirstin Margosian, MA Contracts Coordinator 3 Rachael Fleurence, PhD Program Director
  • 5. PCORI’s Mission and Vision  The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health research organization authorized by the Patient Protection and Affordable Care Act of 2010.  PCORI funds patient-centered research to assist patients, caregivers, and other stakeholders in making informed health decisions. Mission PCORI helps people make informed healthcare decisions and improves healthcare delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers, and the broader healthcare community. Vision Patients and the public have the information they need to make decisions that reflect their desired health outcomes. 5
  • 6. Research Done Differently PCORI’s unique contribution to this field of research is its dedicated focus on outcomes that matter most to patients. Inclusion of patient-centered outcomes is therefore a necessary component of PCORI-funded research. PCORI involves patients and the entire healthcare community in every step of the research process — from selecting research questions to study, to the actual conduct of research, to sharing the research findings through platforms and channels that are accessible to everyone. 6
  • 8. Overview of PFAs To solicit research proposals, PCORI regularly releases funding announcements that invite researchers to submit applications to receive funding to conduct research projects: Addressing Disparities Assessment of Prevention, Diagnosis, and Treatment Options Communication and Dissemination Research Improving Healthcare Systems Improving Methods for Conducting Patient-Centered Outcomes Research 8
  • 9. Improving Methods for Conducting Patient-Centered Outcomes Research 9
  • 10. Improving Methods for Conducting Patient-Centered Outcomes Research 10 In this PFA, we seek to fund projects that:  Improve methods for engaging patients/stakeholders in PCOR and for evaluating the impact of this patient/ stakeholder engagement.  Improve methods for systematic review of PCOR topics, including selection and prioritization of topics.  Improve the validity and/or efficiency of analytic methods and data sources utilized in PCOR research.  Improve methods to support the collection of Patient- Reported Outcomes and Patient-Centered Outcomes.  Improve methods to enhance the reproducibility, transparency, and replication of PCOR research.  Improve approaches for training researchers, patients, and other stakeholders in PCOR methods. Available funds: Up to $8 Million
  • 11. Studies PCORI Is Not Soliciting Under This PFA Studies whose primary focus is not on improving methods for PCOR: Studies should address gaps identified under the research areas of interest in the PFA and the Methodology Committee report. Studies whose primary focus is on developing or studying a disease-specific intervention, model, test, instrument, tool or other items without the primary objective being to address a methodological gap in PCOR as identified in the Methodology Committee report or in other recognized sources. Examples of non-responsive studies: 1. Study whose main focus is to evaluate the response to an intervention in patients with a specific disease. 2. Development of a tool to improve patient-physician communication around a difficult diagnosis. 11
  • 12. Broad Research Topics of Interest The following topics areas are areas of research that PCORI might be interested in:  Development of methods for patient-centeredness.  Research in methods to conduct systematic reviews of patient-centered CER.  Development of methods for generating, selecting, and prioritizing topics for research and for including patients and stakeholders in the peer-review process.  Development and refinement of general analytic methods.  Development and refinement of design-specific analytic methods.  Research that determines the validity and efficiency of data sources commonly used in PCOR.  Research related to Patient-Centered Outcomes (PCOs) and Patient-Reported Outcomes (PROs).  Research in methods to enhance the reproducibility, transparency, and replication of PCOR. 12
  • 14. Merit Review Criteria Applicants must respond to the five PCORI Merit Review Criteria. 1. Impact on the field of PCOR methods 2. Potential for study to improve PCOR methods 3. Technical merit 4. Patient-centeredness 5. Patient and stakeholder engagement 14
  • 15. Criterion 1: Impact on the field of PCOR Methods Refers to the extent that the proposed methods are needed in the field of PCOR.  How often would these methods be used, and how many PCOR studies would benefit from these improved methods?  Do existing methods weaken the validity of PCOR studies, and would improved methods therefore increase the validity of PCOR findings? 15
  • 16. Criterion 2: Potential for study to improve PCOR Methods Refers to the potential of the proposed methodological investigation and its results to change methodological practices in ways that improve PCOR and the decisions made by patients.  Does the research question address a critical gap in current methodological understanding as noted in the Methodology Committee Report or in other sources?  Is the proposed approach feasible and likely to result in new standards or in the improvement of existing standards? 16
  • 17. Criterion 3: Technical merit Refers to the technical merit of the proposal.  Is there a clear research plan with rigorous methods and key milestones clearly articulated? Do the study methods reflect state-of the-art thinking and practice in the methodological area, so that results are likely to be accepted and heeded?  Is the research team appropriately trained and experienced to carry out the planned studies?  Is the research environment sufficient to support the conduct of the work, and are appropriate resources available?  Will the proposed methods help support the inclusion and study of diverse populations with respect to age, gender, race, ethnicity, geography, or clinical status, or, alternatively, do the methods support the inclusion of previously understudied populations in PCOR? 17
  • 18. Criterion 4: Patient-centeredness Refers to the level of patient-centeredness of the proposal.  Is the proposed methodological investigation specifically linked to improving PCOR methods, and specifically to the improved study of comparisons and patient- centered outcomes that are relevant and valued by patients, caregivers, and clinicians?  For relevant studies, how credible are the application’s claims that engaged patients and stakeholders will exert meaningful influence on the design and conduct of the research, to ensure patient-centeredness of the questions and outcomes addressed? 18
  • 19. Criterion 5: Patient and stakeholder engagement Refers to the level of engagement of patients and stakeholders in the proposed project.  Where applicable, applications need to demonstrate patient and stakeholder engagement through the integration of patients and stakeholders in the development of the research plan and in key elements of the proposed project including: • Participation in formulation of research questions • Defining essential characteristics of the study, participants, comparators, and outcomes • Monitoring study conduct and progress • Dissemination of research results  If the project has not included patient and stakeholder engagement (for example, in the area of analytic methods), has the application justified their non-inclusion? 19
  • 20. Letter of Intent (LOI) Submission: Deep Dive 20
  • 21. Understanding the Letter of Intent (LOI) A LOI is required in order to submit an application. LOI’s are NOT scored. Applicants will NOT receive an invitation to submit an application after submitting a LOI. An Investigator can only be listed as a PI on one. Of note: PCORI encourages applicants to submit their LOI and application before the stated due date. LOIs and applications are due 5:00 pm ET. 21
  • 22. Eligibility Requirements Applications may be submitted by:  Any private sector research organization, including any: • non-profit organization • for-profit organization  Any public sector research organization, including any: • university or college • hospital or healthcare system • Laboratory or manufacture • unit of state or local government  Foreign Organizations  Nondomestic Components of Organizations based in the United States Please Note: Individuals are not eligible to submit applications to PCORI. 22
  • 23. Budget and Period Limitations Budget • Maximum $250,000 direct costs per year • Indirect costs are capped at 40% • *Request for exception can be made during the LOI submission Period of Performance • Maximum of three years • PCORI encourages projects of shorter duration • *Request for exception can be made during the LOI submission *Of note: Approval or denial decisions may take up to four months. Please plan accordingly, and factor this into your decision to submit a request. 23
  • 24. Letter of Intent 24 The Letter of Intent includes:  Organizational information  Information about Key Personnel  Technical abstract (3,000 character limit) • Background: State the problem or methodological gap your research intends to address, including the rationale for tackling this problem. • Objectives: Briefly describe the specific aims of the study, including the methods gaps addressed. • Methods: Give a concise description of the steps involved in the development of the new methodology. • Anticipated impact: Describe the anticipated impact the study results will have on the field of PCOR methods. Of note: This abstract may be used to determine programmatic fit.
  • 25. Key Dates: August 15 2013 Key Dates: PCORI Funding Announcements Action August 2013 Cycle System Opening Date May 15 Letter of Intent (LOI) Due Date June 15 Informational Training Programs July – August Application Deadline August 15 Merit Review Dates September - November Awards Announced December / January Earliest Start Date January 25
  • 26. Frequently Asked Questions (Programmatic)  How do I know if my research is of interest to PCORI? • We encourage you to read the PCORI Funding Announcements (PFAs) carefully and other background material on our website to understand our goals and the PFA you are considering.  Can I speak with someone at PCORI about the suitability of my research question? • Currently, PCORI does not have dedicated individuals to speak with applicants regarding submission questions. Applicants and potential applicants with questions should submit those inquiries via pfa@pcori.org.  Is there a specific disease or condition that is a priority for PCORI? • No. PCORI is concerned with patient outcomes, across a range of conditions and treatments. PCORI will periodically issue PFAs that focus on specific diseases or conditions within or across funding areas. 26
  • 27. Frequently Asked Questions (Administrative)  Can I switch PFAs after a LOI has been submitted? • No. It is not possible to submit an LOI to one funding announcement and the full application to another.  How much can the research proposed in my application differ from that initially described in my Letter of Intent (LOI)? • The information provided in the LOI, including the study title, may be changed in the final application. Only two things may not differ: • The PFA may not change. • The budget may not exceed direct cost and/or project period, as listed within the PFA, if permission was not requested at LOI submission.  Can I list a different PI in the final application than was listed in the Letter of Intent (LOI)? • Yes. The PI listed on your final application may differ from the PI listed in the LOI. 27
  • 29. Resources View training materials through the Quick Links for Applicants bar. Access: • Application training • Opportunities for webinars • Reviewer training Visit the Funding Center for: • PFAs • Templates • Instructions • Key dates • FAQ’s 29
  • 30. Questions Submitting Questions: Submit questions via the chat function in Meeting Bridge Ask a question via phone (press #7 on your phone) Please use this time to ask any question you may have about the PFA or the LOI submission process. If we are unable to address your question during this time, e-mail the help desk at pfa@pcori.org. 30